Sentinel Trust’s iShares Biotechnology ETF IBB Stock Holding History

Sentinel Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,725	Closed	-$251K	–	133
2024 Q3	$251K	Hold	1,725	–	–	0.03%	129
2024 Q2	$237K	Hold	1,725	–	–	0.03%	127
2024 Q1	$237K	Hold	1,725	–	–	0.03%	136
2023 Q4	$234K	Hold	1,725	–	–	0.03%	127
2023 Q3	$211K	Hold	1,725	–	–	0.03%	127
2023 Q2	$219K	Hold	1,725	–	–	0.03%	126
2023 Q1	$223K	Hold	1,725	–	–	0.03%	121
2022 Q4	$226K	Hold	1,725	–	–	0.04%	98
2022 Q3	$202K	Hold	1,725	–	–	0.03%	106
2022 Q2	$203K	Sell	1,725 -587	-25%	-$69.7K	0.03%	114
2022 Q1	$301K	Buy	+2,312	New	+$301K	0.04%	113
2013 Q3	–	Sell	-4,380	Closed	-$254K	–	197
2013 Q2	$254K	Buy	+4,380	New	+$253K	0.08%	157

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Sentinel Trust's IBB Position: Q4 2024 in Review

Sentinel Trust sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,725 shares — an estimated $251K sold.

Sentinel Trust first reported a position in IBB in Q2 2013 and held it in 12 quarters. The position peaked at $301K in Q1 2022. 878 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Sentinel Trust reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Sentinel Trust sold 1,725 iShares Biotechnology ETF shares in Q4 2024, an estimated $251K.
Sentinel Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 12 quarters.
Sentinel Trust's iShares Biotechnology ETF position peaked at $301K in Q1 2022.
878 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Sentinel Trust's 13F filing for Q4 2024, filed 5 Feb 2025.